Nika Pharmaceuticals NIKA Income Statement (2021-2023)

OTC NIKA
$0.42 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Operating items
Research & Development (Quarter) 3.00M
Selling, General & Administrative (Quarter) 0.01M0.00M0.00M0.00M0.01M0.01M0.01M0.02M0.02M0.03M0.01M
Restructuring Costs (Quarter) 0.15M
Operating Expenses (Quarter) 0.01M0.00M0.00M0.00M0.01M3.16M0.01M0.02M0.02M0.03M0.01M
Operating Income (Quarter) -0.01M-0.00M-0.00M-0.00M0.01M-3.16M-0.01M-0.02M0.02M-0.03M-0.01M
EBIT (Quarter) -0.01M-0.00M-0.00M-0.00M0.01M-3.16M-0.01M-0.02M0.02M-0.03M-0.01M
Net income details
EBT (Quarter) -0.01M0.00M0.00M-0.03M0.01M-3.16M-0.01M-0.02M-0.02M-0.03M-0.01M
Profit After Tax (Quarter) 0.01M0.00M0.00M-0.03M-0.01M-3.16M-0.01M-0.02M-0.02M-0.03M-0.01M
Income from Continuing Operations (Quarter) -0.01M0.00M0.00M-0.03M0.01M-3.16M-0.01M-0.02M-0.02M-0.03M-0.01M
Consolidated Net Income (Quarter) -0.01M0.00M0.00M-0.03M0.01M-3.16M-0.01M-0.02M-0.02M-0.03M-0.01M
Income towards Parent Company (Quarter) -0.01M0.00M0.00M-0.03M0.01M-3.16M-0.01M-0.02M-0.02M-0.03M-0.01M
Net Income towards Common Stockholders (Quarter) -0.01M0.00M0.00M-0.03M0.01M-3.16M-0.01M-0.02M-0.02M-0.03M-0.01M
Additional items
EPS (Basic) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.00
EPS (Diluted) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.00
Shares Outstanding (Quarter) 13.20M13.20M13.20M13.20M13.20M740.60M740.60M723.95M876.09M876.09M876.09M876.09M
Shares Outstanding (Diluted) (Quarter) 13.20M396.09M396.09M396.09M13.20M740.60M740.60M723.95M876.09M876.09M876.09M876.09M
Shares Outstanding (Entity) (Quarter) 13.20M13.20M13.20M13.20M13.20M876.09M876.09M723.95M876.09M876.09M876.09M876.09M
EBITDA (Quarter) -0.01M-0.00M-0.00M-0.00M0.01M-3.16M-0.01M-0.02M0.02M-0.03M-0.01M
Interest Expenses (Quarter) 0.03M0.70M0.71M